pharmacotherapy after myocardial infarction the reality of coronary prevention in brno, or else is...
TRANSCRIPT
![Page 1: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/1.jpg)
Pharmacotherapy after myocardial infarctionPharmacotherapy after myocardial infarctionPharmacotherapy after myocardial infarctionPharmacotherapy after myocardial infarction
The reality of coronary prevention in BrnoThe reality of coronary prevention in Brno,,or else Is pharmacotherapy after myocardial infaction sufficientor else Is pharmacotherapy after myocardial infaction sufficient..
The reality of coronary prevention in BrnoThe reality of coronary prevention in Brno,,or else Is pharmacotherapy after myocardial infaction sufficientor else Is pharmacotherapy after myocardial infaction sufficient..
![Page 2: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/2.jpg)
REPERFUSION
![Page 3: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/3.jpg)
PTCA
![Page 4: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/4.jpg)
Direct PCI for all STEMI
![Page 5: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/5.jpg)
PTCA
60/1,000,000 = 1992
624/1,000,000 = 1998
1,220/1,000,000 = 2006
20x
![Page 6: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/6.jpg)
PTCA
60/1,000,000 = 1992
624/1,000,000 = 1998
1,220/1,000,000 = 2006
2,250/1,000,000 = 2009
37x
![Page 7: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/7.jpg)
STENT
5/1 000 000 = 1992449/1 000 000 = 1998
1 082/1 000 000 = 2007
200x
![Page 8: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/8.jpg)
STENT
5/1 000 000 = 1992449/1 000 000 = 1998
1 082/1 000 000 = 20072 850/1 000 000 = 2009
570x
![Page 9: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/9.jpg)
REMODELATION REPERFUSION
RETHROMBOSIS RESTENOSIS 4R
![Page 10: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/10.jpg)
Beta blockadeRAAS blockade
Statins Antiaggregation
![Page 11: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/11.jpg)
Registry Brno 2Registry Brno 2Registry Brno 2Registry Brno 2
![Page 12: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/12.jpg)
Methods
Collection of data on patients with history of myocardial infarction > 1 month.
Outpatient follow-up in University Hospital Brno from 1 Sept. 2009 to 31 Dec. 2009.
Brno 2 registry of patient post myocardial infarction
![Page 13: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/13.jpg)
Institute of Biostatistics and Analyses Masaryk Universitywww.iba.muni.cz; www.muni.cz
23,5%
76,5%
850 pts - age and gender
Number %
Total 850
Gender M (male) 650 76.5%
F (female) 200 23.5%
Age70 years or
younger576 68.6%
over 70 years
264 31.4%
Age – mean (SD);median (5-95%)
64 (10.8); 64 (46-82)
0,5 1,0
3,3
5,5
8,8
15,7
19,4
14,313,5
11,4
5,1
1,20,2
0
2
4
6
8
10
12
14
16
18
20
Age (years)
% o
f p
ati
en
ts
Age (category)
31,4%
68,6%
70 years or younger
over 70 years
Gender
Male Female
N = 850
![Page 14: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/14.jpg)
Institute of Biostatistics and Analyses Masaryk Universitywww.iba.muni.cz; www.muni.cz
Number of myocardial infarctions and age at the first infarction
Total Male Female70 years or
youngerover 70 years
Number of MIs:
1 x MI 87.8% 87.5% 88.5% 90.3% 83.0%
2 x MI 9.5% 9.5% 9.5% 8.0% 12.1%
more than 2 x MI 2.7% 2.9% 2.0% 1.7% 4.9%
0,1 0,10,7
2,2
5,8
9,3
12,6
19,6
16,7
13,4
10,2
6,9
1,9
0,4
0
2
4
6
8
10
12
14
16
18
20
Age at time of first MI (years)
% o
f p
ati
en
ts
N = 850
1st MITotal 60.5 yearsMen 59.0 yearsWomen 65.5 years
![Page 15: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/15.jpg)
Institute of Biostatistics and Analyses Masaryk Universitywww.iba.muni.cz; www.muni.cz
Blood pressure
39,9%
40,9%
19,2%
less than 130/80 130/80 to 140/90 more than 140/90
Total (N=850)
44,5%
36,5%
19,0%
38,5%
42,3%
19,2%
42,0%
38,6%
19,3%
38,5%
42,4%
19,1%
Men (N=650)
Women (N=200)
70 years or younger (N=576)
over 70 years (N=264)
![Page 16: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/16.jpg)
Institute of Biostatistics and Analyses Masaryk Universitywww.iba.muni.cz; www.muni.cz
Blood pressure categories
12,8
12,9
12,5
12,8
12,5
27,4
28,2
25,0
28,6
25,0
19,9
20,5
18
20
20,5
8,7
8,5
9,5
8
10,6
4
4
4
4,3
3
19,6
18,9
22
17,2
24,6
6,6
6,2
8
8
3
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Total (N=850)
Men (N=650)
Women (N=200)
70 yrs and younger (N=604)
over 70 years (N=264)
Optimal BP Normal BP High normal BP
HT 1st degree
HT 2nd degree
HT isol. diastolic
HT isol. systolic
HT 3rd degree
.
* significant difference at level 0.05
![Page 17: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/17.jpg)
Institute of Biostatistics and Analyses Masaryk Universitywww.iba.muni.cz; www.muni.cz
Blood pressure
N = 850
mm
Hg
75%
Median
25%
95%
5%
BP - systole
mm
Hg
BP - diastole
over 70 years
70 years or younger
FemaleMaleTotal
70 years or
younger
70 years or
younger
Over 70 years Over 70 yearsTotal Men Women Total Men Women
![Page 18: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/18.jpg)
Institute of Biostatistics and Analyses Masaryk Universitywww.iba.muni.cz; www.muni.cz
Heart rate
N = 850
75%
Median
25%
95%
5%
Pulse (per minute)
over 70 years
70 years or younger
FemaleMaleTotal
# significant difference at level <0.001
# 70 years or
younger
Over 70 yearsTotal Men Women*
![Page 19: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/19.jpg)
Institute of Biostatistics and Analyses Masaryk Universitywww.iba.muni.cz; www.muni.cz
Cholesterol
27,5%
17,6%
54,9%
less than 4.5 mmol/l
4.5 to 5 mmol/l more than 5 mmol/l
35,6%
16,0%
48,4%
25,0%
18,1%
56,9%
30,4%
16,9%
52,7%
20,6%
19,3%60,1%
****
* significant difference at level 0.05** significant difference at level 0.01
Total (N=850)
Men (N=650)
Women (N=200)
70 years or younger (N=576)
over 70 years (N=264)
![Page 20: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/20.jpg)
BP < 140/90 mmHg – 60.1%ISH – 19.6%
Cholesterol < 5 mmol/l - 72.5%
Brno 2 Achievement of target values
![Page 21: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/21.jpg)
Institute of Biostatistics and Analyses Masaryk Universitywww.iba.muni.cz; www.muni.cz
Medication
ACEI or ARB
only ACEI
only ARB
ACEI and ARB
Betablocker
Statins
ASA or Clop.
only ASA
only Clop.
ASA and Clop.
93,1
76,3
16,2
0,6
91,7
93,1
94,9
76,6
0,0
18,3
0 50 100
89,4
65,0
23,6
0,5
91,0
89,4
91,0
74,0
0,5
16,5
0 50 100
92,3
75,0
16,9
0,3
93,1
94,8
95,8
74,8
0,0
21,0
0 50 100 150
91,7
71,2
19,3
1,1
87,8
86,7
89,8
78,0
0,4
11,4
0 50 100
Total (N=850) Men (N=650) Women (N=200) 70 yrs or younger (N=576)
over 70 years (N=264)
92,2
73,6
17,9
0,6
91,5
92,6
94,0
76,0
0,1
17,9
0 50 100
RAAS Betablockers Statins Antiaggregation
![Page 22: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/22.jpg)
Institute of Biostatistics and Analyses Masaryk Universitywww.iba.muni.cz; www.muni.cz
Medication – drug combinations
75,8 77,769,5
81,1
63,6
19,6 18,5
23,5
15,5
29,2
3,5 3,2 52,4
6,1
0%
20%
40%
60%
80%
100%
Celkem Muži Ženy do 70 let nad 70 let
All groups Triple combination Double combination 1 group of drugs
Antiaggregation - 0.5%
RAAS - 0.2%
Statins - 0.2%
BB-Antiaggregation - 1.1%
BB-Statins - 0.2%
RAAS-Antiaggregation - 0.9%
RAAS-BB - 0.2%
RAAS-Statins - 0.7%
Statins-Antiaggregation - 0.4%
BB-Statins-Antiaggregation - 5.4%
RAAS-BB-Antiaggregation - 4.5%
RAAS-BB-Statins - 4.2%
RAAS-Statins-Antiaggregation - 5.5%
N = 850
![Page 23: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/23.jpg)
low intermediate high
Perindopril < 2.5 2.5 – 9.9 > 10
Ramipril < 2.5 2.5 – 9.9 > 10
Trandolapril < 0.5 0.6 – 3.9 > 4
Brno 2 ACE inhibitors
![Page 24: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/24.jpg)
Institute of Biostatistics and Analyses Masaryk Universitywww.iba.muni.cz; www.muni.cz
ACEI dosing
ACEI
(N= 631)
Perindropril
(N= 271)
Ramipril
(N= 240)
Trandolapril
(N= 51)
40,3
40,4
40
41,3
38,1
26,9
25,7
31,6
26,4
29,4
62,8
64,4
56,9
67,1
53,2
31,4
31,7
30
34,2
23,1
44,4
44,4
44,6
44,6
43,9
61,6
62,6
57,9
61,7
61,8
24,7
22,9
31,4
22,8
29,1
54,9
53,7
60,0
55,3
53,8
15,3
15,3
15,4
14,1
18
11,4
11,7
10,5
11,9
8,8
12,6
12,8
11,8
10,1
17,7
13,7
14,6
10
10,5
23,1
0% 20% 40% 60% 80% 100%
Total
Men
Women
70 or younger
over 70
Total
Men
Women
70 or younger
over 70
Total
Men
Women
70 or younger
over 70
Total
Men
Women
70 or younger
over 70
low dose moderate dose high dose
![Page 25: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/25.jpg)
low intermediate high
Metoprolol < 25 25 – 199 > 200
Bisoprolol < 2.5 2.5 – 9.9 > 10
Carvedilol < 12.5 12.5 - 49.9 > 50
Brno 2 betablockers
![Page 26: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/26.jpg)
Institute of Biostatistics and Analyses Masaryk Universitywww.iba.muni.cz; www.muni.cz
Batablocker dosing
Betablocker
(N= 777)
Metoprolol
(N= 312)
Bisoprolol
(N= 252)
Carvedilol
(N= 124)
44,5
45
43,1
44
45,9
26,6
26,4
27,1
25,2
30,1
62,3
64
53,7
60,1
70,8
54
49,4
65,7
50,7
57,4
41,1
40,4
43,1
40,5
42,0
60,3
59,9
61,2
59,9
60,2
34,1
32,7
41,5
36,0
27,1
32,3
36,0
22,9
30,4
35,2
14,4
14,6
13,8
15,5
12,1
13,1
13,7
11,8
14,9
9,7
3,6
3,3
4,9
3,9
2,1
13,7
14,6
11,4
18,8
7,4
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Total
Men
Women
70 or younger
over 70
Total
Men
Women
70 or younger
over 70
Total
Men
Women
70 or younger
over 70
Total
Men
Women
70 or younger
over 70
low dose moderate dose high dose
![Page 27: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/27.jpg)
low intermediate high
Atorvastatin < 10 11 – 79 > 80
Simvastatin < 20 21 – 79 > 80
Fluvastatin < 20 21 – 79 > 80
Brno 2 statins
![Page 28: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/28.jpg)
Institute of Biostatistics and Analyses Masaryk Universitywww.iba.muni.cz; www.muni.cz
Statin dosing
Statins
(N= 786)
Atorvastatin
(N= 555)
Simvastatin
(N= 123)
Fluvastatin
(N= 75)
16,3
15,9
17,9
13,4
24,1
7,2
7,3
7,1
7,4
7
70,2
70
71
59,2
86
67,9
67,4
69,8
70,9
60,1
87,7
86,7
91,3
86,9
89,4
26,4
25,6
29,0
35,2
14,0
2,7
3,4
2,2
3,4
15,7
16,7
12,3
15,8
15,8
5,1
6,1
5,7
3,5
3,3
4,4
5,6
97,3
96,6
100
97,8
96,6
0% 20% 40% 60% 80% 100%
Total
Men
Women
70 or younger
over 70
Total
Men
Women
70 or younger
over 70
Total
Men
Women
70 or younger
over 70
Total
Men
Women
70 or younger
over 70
low dose moderate dose high dose
![Page 29: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/29.jpg)
4 drug groups 75.8%
RAAS blockade 92.2%
Beta blockade 91.5%
Statins 92.6%
Antiaggregation 94.0%
Brno 2 Pharmacotherapy - 1
![Page 30: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/30.jpg)
High dose ACEI 15.3%
Perindopril 11.4%
High dose statins 15.7%
Atorvastatin 5.1%
Brno 2 Pharmacotherapy - 2
![Page 31: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/31.jpg)
Average age Men 59.0 years
Average age Women 65.5 years
Brno 2 Conclusions - 1
![Page 32: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/32.jpg)
BP < 140/90 60.1%
ISH 19.6%
Chol < 5.0 mmol/l 72.5%
All 4 drugs 75.8%
Each drug group > 90%
Brno 2 Conclusions - 2
![Page 33: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/33.jpg)
Insufficient dosing of ACEI, betablockers and statins
Brno 2 Conclusions - 3
![Page 34: Pharmacotherapy after myocardial infarction The reality of coronary prevention in Brno, or else Is pharmacotherapy after myocardial infaction sufficient](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e675503460f94b6295f/html5/thumbnails/34.jpg)
Czech republic is among the best in Europe in pharmacotherapy of patients post MI and
in achievement of target values.
Brno 2 Conclusions - 4